Mukka Proteins Ltd Stock Price Today (NSE: MUKKA)

Mukka Proteins Ltd

24.910.28 (1.11%)
Market Closed

Fundamental Score

...

Mukka Proteins Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Mukka Proteins Ltd share price today is 24.91, down 1.11% on NSE/BSE as of 17 June 2026. Mukka Proteins Ltd (MUKKA) is a Small-cap company in the Animal Feed sector with a market capitalisation of 770.99 (Cr). The 52-week high for MUKKA share price is 31.23 and the 52-week low is 18.27. At a P/E ratio of 16.32x, MUKKA is currently trading below its industry average P/E of 18.96x. The company has a Return on Equity (ROE) of 11.10% and a debt-to-equity ratio of 1.37.

Mukka Proteins Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
25.49
Low
22.20
Volume
2.1L
Change
-5.11%

Mukka Proteins Ltd share price chart: -5.11% return over the past month. 52-week high ₹31.23, 52-week low ₹18.27.

Mukka Proteins Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
22.0622.6721.9622.383.03L (Cr)
22.6823.3922.1622.261.87L (Cr)
23.2123.6122.6022.792.62L (Cr)
22.9523.4322.9023.211.43L (Cr)
23.0123.4522.8222.951.50L (Cr)
22.5223.2022.5223.141.25L (Cr)
22.6922.9422.2022.411.29L (Cr)
22.7123.1322.5522.671.76L (Cr)
22.5023.0222.5022.691.28L (Cr)
23.0023.3022.9022.941.04L (Cr)

Mukka Proteins Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
22.6823.3921.9622.38-1.32%
24.1025.4922.2022.79-5.44%
19.4924.8819.0124.03+23.29%
21.0023.5318.2718.49-11.95%
23.0526.5022.3322.76-1.26%
24.1424.1820.1623.30-3.48%
25.4030.2623.6524.02-5.43%
25.0527.5023.8025.29+0.96%
26.1427.6524.1025.18-3.67%
26.7231.2325.8726.13-2.21%
28.5928.8024.7526.61-6.93%
30.1330.1827.9128.44-5.61%

AI Research Briefing

Powered by Gemini · 2026-04-15

Leveraged fishmeal play with stretched valuation and negative FCF; avoid until commodity cycle turns or waste-to-value scales.

Research Confidence
6.0/10Moderate
MICRO-CAP DARK HORSEBreakdown — 1M: 2.14%, 3M: -7.71%, 6M: -17.27%.Fair — P/E of 16.32x vs Industry P/E of 18.96x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Mukka Proteins completed the acquisition of Haris Marine Products subsidiary. The stock hit a fresh all-time low of on March 30, 2026, amidst broader sector weakness.

CORE STORY (THE REAL GAME)

Commodity fishmeal play leveraged to aquaculture growth, with a side bet on waste-to-value solutions. Carbon credit potential is a small kicker.

Why Now
  • Q3 revenue beat
  • Haris Marine acquisition complete
  • Waste management order win
Potential Catalysts
  • Sustained high fishmeal prices
  • Successful scaling of waste-to-value business
  • Debt reduction
Key Risks
  • High debt/equity ratio
  • Negative free cash flow
  • Small-cap liquidity risk
Institutional Activity

FII and DII holdings decreased.

Macro Context

Indian animal feed market projected to reach $15 billion by the end of 2026, growing at a CAGR of over 6%.

Order Book / Expansion

₹474.89 crore work order from Bengaluru Solid Waste Management Limited (BSWML).

Cash Flow Quality

No — Free Cash Flow 5Y: ₹-376.69 Cr.

3–6 Month Outlook

Next 3-6 months depend on fishmeal prices and execution of the waste management order. Vietnam acquisition delayed to June 30, 2026.

Primary Thesis Risk

Fishmeal price collapse will trigger a debt spiral.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

11.10%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

11.59%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

7.22%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Mukka Proteins Ltd Valuation Check

Good

Price to Earnings (P/E)

16.32x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

18.96x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

73.33%

% shares held by company founders/management

Poor

FII Holding

1.70%

% shares held by foreign institutional investors

Poor

DII Holding

1.66%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

182.69%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

63.93%

Revenue growth vs same quarter last year

Good

Revenue Growth (5-Year CAGR)

12.88%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

32.54%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.37x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

2.43x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-376.69 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Mukka Proteins Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of MUKKA across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Robust Profit Growth (182.69%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (63.93%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (12.88% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (32.54% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Balanced Promoter Holding (73.33%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Elevated Debt Levels (D/E: 1.37)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Weak Interest Coverage (2.43x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-376.69 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 3.36%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Mukka Proteins Ltd vs Animal Feed Peers

Peer Comparison - Animal Feed

Compare Mukka Proteins Ltd with 7 other companies in the same sector

8 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
51.1/100
25
₹770.99
16.3
Average
11.10%
Average
11.59%
Average
1.4
Average
32.54%
Excellent
12.88%
Good
0.00%
32.8/100
593
₹11708.23
26.9
Average
17.68%
Good
16.59%
Good
1.2
Average
6.68%
Good
6.14%
Good
1.81%
64.8/100
1297
₹10813.08
17.5
Average
19.53%
Good
23.99%
Excellent
0.0
Excellent
8.20%
Good
6.40%
Good
1.13%
Kse Ltd...
KSE519421
59.1/100
2329
₹772.00
6.1
Average
33.98%
Excellent
42.92%
Excellent
0.1
Excellent
36.23%
Excellent
2.92%
Average
3.32%
49.2/100
212
₹111.78
20.4
Average
16.79%
Good
16.45%
Good
0.9
Good
63.01%
Excellent
24.07%
Excellent
0.00%
33.9/100
9
₹111.27
32.0
Average
8.28%
Poor
11.38%
Average
0.6
Good
0.00%
42.8/100
37
₹88.29
23.1
Average
11.24%
Average
13.05%
Average
0.2
Excellent
38.94%
Excellent
1.03%
Average
0.00%
51.9/100
4
₹81.64
20.5
Average
5.15%
Poor
6.91%
Poor
0.1
Excellent
55.56%
Excellent
23.40%
Excellent
0.00%

Mukka Proteins Ltd PE Ratio History

Historical price-to-earnings ratio for MUKKA — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20243.10₹41.2413.3x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Mukka Proteins Ltd Quarterly Performance

Latest quarterly metrics for MUKKA — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

63.93%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

182.69%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

12.88%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

32.54%

Compounded annual net profit growth over 5 years

Mukka Proteins Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for MUKKA — calculated from daily price history

30RSI 14
Neutral — RSI 30

Momentum is balanced — neither overbought nor oversold.

SMA 50
23
▲ Price above SMA 50 — Short-term bullish
SMA 200
24
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
256K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Mukka Proteins Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Mukka Proteins Ltd (MUKKA) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Mukka Proteins Ltd

About MUKKA (Mukka Proteins Ltd)

Mukka Proteins Ltd is a pioneering force in the animal feed industry, specializing in the sustainable production of high-quality protein ingredients derived from fish and insects. ...With a commitment to innovation and environmental responsibility, Mukka Proteins transforms marine and insect resources into valuable components for various sectors. The company’s state-of-the-art facilities employ advanced processing techniques to ensure optimal nutrient retention and product purity. Mukka Proteins is dedicated to meeting the evolving needs of the animal feed market while minimizing its ecological footprint. Their products offer a superior alternative to conventional protein sources, promoting healthier animal growth and improved overall nutrition. Mukka Proteins Ltd offers a comprehensive portfolio of products tailored to diverse applications. Their flagship offerings include fish meal, fish oil, and fish soluble paste, all meticulously crafted to provide essential amino acids, omega-3 fatty acids, and other vital nutrients for aqua feed, poultry feed, and pet food formulations. Furthermore, Mukka Proteins extends its expertise to insect-based ingredients with ento meal, ento oil, and compost, harnessing the potential of insects as a sustainable protein source. These innovative products cater to the growing demand for eco-friendly and nutritionally superior feed ingredients. Beyond animal nutrition, the company supplies raw materials for industrial uses such as soap manufacturing, leather tanning, and paint production. With a global outlook, Mukka Proteins Ltd has established a robust export network, serving customers across Asia and beyond. Their commitment to quality and reliability has earned them a reputation as a trusted supplier in international markets. By providing consistent product performance and exceptional customer service, Mukka Proteins fosters long-term partnerships with businesses worldwide. As the animal feed industry continues to prioritize sustainability and nutritional excellence, Mukka Proteins is poised to play a key role in shaping the future of animal nutrition with its innovative product offerings and commitment to responsible resource management.

Company Details

Symbol:MUKKA
Industry:Animal Feed
Sector:Animal Feed

Key Leadership

Mr. Kalandan Mohammed Haris
MD, CEO & Director
Mr. Kalandan Abdul Razak
Founder & Non-Executive Director
Mr. Kalandan Mohammed Althaf
CFO & Whole Time Director

MUKKA Share Price: Frequently Asked Questions

What is the current share price of Mukka Proteins Ltd?

Mukka Proteins Ltd (MUKKA) trades at ₹24.91 on NSE and BSE. Market cap ₹770.99 (Cr). Educational data only.

What is the P/E ratio of Mukka Proteins Ltd?

Mukka Proteins Ltd has a P/E of 16.32x vs industry average 18.96x.

What is the Bull Run score for Mukka Proteins Ltd?

Mukka Proteins Ltd has a Bull Run score of 51.1/100 based on 25+ financial parameters.

Does Mukka Proteins Ltd pay dividends?

Mukka Proteins Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Mukka Proteins Ltd?

Mukka Proteins Ltd has ROE of 11.10%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Mukka Proteins Ltd?

Mukka Proteins Ltd has debt-to-equity of 1.37.

Is Mukka Proteins Ltd a good investment?

Bull Run gives Mukka Proteins Ltd a score of 51.1/100. This is not investment advice — consult a SEBI-registered advisor.